Alpha Tau Medical

DRTSAlpha Tau Medical

About Alpha Tau Medical

Alpha Tau Medical (NASDAQ:DRTS) specializes in developing cancer treatments based on its pioneering Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) technology. This advanced technology targets solid tumors with high precision, offering a new hope in the fight against cancer. Currently engaged in various stages of clinical trials across multiple cancer types, the company aims to transform cancer treatment paradigms by providing highly effective, localized therapy with minimal side effects. With an objective to broaden the horizon of cancer care, Alpha Tau Medical is committed to advancing its research and expanding the application of its technology to benefit patients worldwide.

What is DRTS known for?

Snapshot

Public US

Ownership

2015

Year founded

121

Employees

Tel Aviv, Israel

Head office

Loading Map...

Operations

All Locations

State of Israel

Products and/or services of Alpha Tau Medical

Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) - A breakthrough technology for treating solid tumors by delivering high-precision alpha radiation directly to the cancerous site.
R&D Services - Provides research and development services in the field of alpha radiation therapy, including preclinical studies and clinical trial design.
Consulting Services - Offers expert consulting in radiopharmaceuticals, providing insights and strategies for developing and commercializing alpha radiation therapies.
Training Programs - Develops and delivers training programs for healthcare professionals on the safe and effective use of alpha radiation therapy in treating cancer.
Partnership Programs - Engages in strategic partnerships to advance the development and application of alpha radiation therapy in oncology.
Technology Licensing - Licenses its proprietary alpha radiation therapy technology to other companies for development and commercialization in specific territories.